Retina/Vitreous News

CHICAGO — In this Healio Video Perspective from the AAO meeting, Allen C. Ho, MD, of Wills Eye Hospital shares promising results of a phase 2b/3 trial investigating MCO-010 optogenetic therapy for the treatment of retinitis pigmentosa.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Pravin U. Dugel, MD, of Ocular Therapeutix discusses the next steps for the phase 3 SOL-1 and SOL-R studies.

CHICAGO — Teleretinal screening for diabetic retinopathy has several benefits, including increased capacity and better compliance, according to a speaker at the American Academy of Ophthalmology meeting.

CHICAGO — Different imaging modalities are effective for the diagnosis of geographic atrophy, according to a speaker at the American Academy of Ophthalmology meeting.

CHICAGO — Decreasing vitamin A dimerization may be a promising treatment avenue for treating geographic atrophy, according to a speaker here.

CHICAGO — A Fas inhibitor showed strong efficacy signals and demonstrated neuroprotection in patients with more than 8 days of macula-off rhegmatogenous retinal detachment, according to a study.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Jeremiah Brown, MS, MD, presents results from the phase 4 Elevatum trial investigating faricimab for diabetic macular edema.

CHICAGO — Physicians and engineers need to work together to advance surgical technology, according to a speaker at Retina Subspecialty Day at the American Academy of Ophthalmology meeting.

BARCELONA, Spain — Adopting specific treatment regimens, reducing patient and staff travel, and limiting the use of unnecessary personal protective equipment can help improve the carbon footprint of intravitreal injections.

Filling an opioid prescription after ophthalmic surgery was associated with higher rates of hospitalization, overdose, abuse or dependency, and mortality, according to a study published in Ophthalmology.